T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,630.00
+415.00 (9.85%)
May 13, 2025, 3:30 PM KST
-43.61%
Market Cap 99.76B
Revenue (ttm) 4.87B
Net Income (ttm) -7.68B
Shares Out 21.55M
EPS (ttm) -356.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151,174
Average Volume 97,670
Open 4,350.00
Previous Close 4,215.00
Day's Range 4,250.00 - 4,745.00
52-Week Range 2,840.00 - 8,550.00
Beta 0.84
RSI 51.82
Earnings Date May 14, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.